Stéphane Grillet

Impact of synthetic and biologic disease-modifying antirheumatic drugs on antibody responses to the AS03-adjuvanted pandemic influenza vaccine: A prospective, open-label, parallel-cohort, single-center study

Cem Gabay, Michael Bel, Christophe Combescure et al. · Arthritis & Rheumatism · 2011 · 138 citations

Varicella-Zoster Immunization in Pediatric Liver Transplant Recipients: Safe and Immunogenic

Klara M. Posfay‐Barbe, Laure F. Pittet, C. Sottas et al. · American Journal of Transplantation · 2012 · 114 citations · Full text

Transplantation Medicine, Immunology, Vzv-specific Cd4 +19

Determinants of antibody persistence across doses and continents after single-dose rVSV-ZEBOV vaccination for Ebola virus disease: an observational cohort study

Angela Huttner, Sélidji Todagbé Agnandji, Christophe Combescure et al. · The Lancet Infectious Diseases · 2018 · 79 citations · Full text

Vaccination, Single-dose Rvsv-zebov Vaccination, Antibody Persistence +7

Graft-versus-host disease is the major determinant of humoral responses to the AS03-adjuvanted influenza A/09/H1N1 vaccine in allogeneic hematopoietic stem cell transplant recipients

Bilal Mohty, Miquel Jordi Bel, Marija Vukicevic et al. · Haematologica · 2011 · 62 citations · Full text

A dose-dependent plasma signature of the safety and immunogenicity of the rVSV-Ebola vaccine in Europe and Africa

Angela Huttner, Christophe Combescure, Stéphane Grillet et al. · Science Translational Medicine · 2017 · 62 citations · Full text